GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » Net Margin %

Guangdong Hybribio Biotech Co (SZSE:300639) Net Margin % : -91.87% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Guangdong Hybribio Biotech Co's Net Income for the three months ended in Sep. 2024 was ¥-185.0 Mil. Guangdong Hybribio Biotech Co's Revenue for the three months ended in Sep. 2024 was ¥201.4 Mil. Therefore, Guangdong Hybribio Biotech Co's net margin for the quarter that ended in Sep. 2024 was -91.87%.

The historical rank and industry rank for Guangdong Hybribio Biotech Co's Net Margin % or its related term are showing as below:

SZSE:300639' s Net Margin % Range Over the Past 10 Years
Min: -33.97   Med: 19.93   Max: 31.88
Current: -33.97


SZSE:300639's Net Margin % is ranked worse than
64.02% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: -6.515 vs SZSE:300639: -33.97

Guangdong Hybribio Biotech Co Net Margin % Historical Data

The historical data trend for Guangdong Hybribio Biotech Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Hybribio Biotech Co Net Margin % Chart

Guangdong Hybribio Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.19 26.77 31.88 30.84 12.72

Guangdong Hybribio Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.19 -12.46 -7.84 -27.71 -91.87

Competitive Comparison of Guangdong Hybribio Biotech Co's Net Margin %

For the Diagnostics & Research subindustry, Guangdong Hybribio Biotech Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Hybribio Biotech Co's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangdong Hybribio Biotech Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Guangdong Hybribio Biotech Co's Net Margin % falls into.


;
;

Guangdong Hybribio Biotech Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Guangdong Hybribio Biotech Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=140.472/1104.454
=12.72 %

Guangdong Hybribio Biotech Co's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-184.994/201.359
=-91.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangdong Hybribio Biotech Co  (SZSE:300639) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Guangdong Hybribio Biotech Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Hybribio Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.
Executives
Xie Long Xu Directors, executives
Li Qing Hui Executives
Wang Jian Yu Directors, executives
Guan Zhi Sheng Directors, executives
Qiu Mei Lan Supervisors
Yuan Xian Securities Affairs Representative
Tang You Gen Independent director
Cai Dan Ping Director
Chen Yi Directors, executives
Xu Wan Jian Supervisors
Huang Wei Xiong Director
Guan Qiao Zhong Directors, executives

Guangdong Hybribio Biotech Co Headlines

No Headlines